EGFR and breast carcinoma: conducted that in 2D and 3D culture systems of EGFR/HER2-expressing SKBR3 breast cancer cells whose VPS4B is selectively downregulated under hypoxic conditions, EGF-induced EGFR degradation is attenuated.